US 10314885
Oxytocin treatment to modify blood glucose and treat metabolic disease
granted A61KA61K38/095A61K9/0043
Quick answer
US patent 10314885 (Oxytocin treatment to modify blood glucose and treat metabolic disease) held by The Regents of the University of California expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jun 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K38/095, A61K9/0043, A61P, A61P25/00